The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 00653A107 | 11,662 | 1,165,000 | SH | SOLE | 1,165,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 36,467 | 1,746,500 | SH | SOLE | 1,746,500 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 3,665 | 932,500 | SH | SOLE | 932,500 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 500 | 22,200 | SH | SOLE | 22,200 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 3,711 | 890,000 | SH | SOLE | 890,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 5,757 | 537,500 | SH | SOLE | 537,500 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 6,205 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 6,579 | 182,000 | SH | SOLE | 182,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 2,591 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 4,125 | 123,000 | SH | SOLE | 123,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 8,208 | 55,500 | SH | SOLE | 55,500 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 14,158 | 1,752,218 | SH | SOLE | 1,752,218 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 3,321 | 117,500 | SH | SOLE | 117,500 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 7,405 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 7,872 | 765,000 | SH | SOLE | 765,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 9,054 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 18,050 | 340,500 | SH | SOLE | 340,500 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 2,042 | 407,500 | SH | SOLE | 407,500 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 8,793 | 1,497,900 | SH | SOLE | 1,497,900 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 13,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 4,318 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 2,808 | 292,500 | SH | SOLE | 292,500 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 2,358 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 2,100 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 19,315 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 8,523 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 16,196 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 3,506 | 687,500 | SH | SOLE | 687,500 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 6,554 | 1,280,000 | SH | SOLE | 1,280,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 8,694 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 14,222 | 872,500 | SH | SOLE | 872,500 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 10,272 | 823,169 | SH | SOLE | 823,169 | 0 | 0 | ||
LIFESCI ACQUISITION CORP | UNIT 03/31/2025 | 53228P208 | 6,160 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 14,801 | 632,500 | SH | SOLE | 632,500 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 7,401 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,387 | 15,300 | SH | SOLE | 15,300 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 10,494 | 234,500 | SH | SOLE | 234,500 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 1,007 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 6,714 | 2,364,204 | SH | SOLE | 2,364,204 | 0 | 0 | ||
SURFACE ONCOLOGY INC | COM | 86877M209 | 1,476 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,568 | 240,744 | SH | SOLE | 240,744 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 2,704 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 4,558 | 2,650,000 | SH | SOLE | 2,650,000 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 5,203 | 127,000 | SH | SOLE | 127,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 1,119 | 107,500 | SH | SOLE | 107,500 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,489 | 517,500 | SH | SOLE | 517,500 | 0 | 0 |